Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Are Bacteriocins Underexploited? NOVEL Applications for OLD Antimicrobials

Author(s): Manuel Montalban-Lopez, Marina Sanchez-Hidalgo, Eva Valdivia, Manuel Martinez-Bueno and Mercedes Maqueda

Volume 12, Issue 8, 2011

Page: [1205 - 1220] Pages: 16

DOI: 10.2174/138920111796117364

Price: $65

Abstract

Bacteriocins are ribosomally synthesized (poly)peptides produced by almost all prokaryotic lineages. Bacteriocins from lactic acid bacteria (LAB) and bacteriocin-producer probiotic organisms have been thoroughly studied due to their wide spectra of action, the long-term use in food fermentations and the consideration of these microorganisms as beneficial for human beings. Most of the studies on the biotechnological application of diverse bacteriocins have been focused on their use as food preservatives, nisin being the prototype successfully used in alimentation. However, bacteriocins from LAB have demonstrated a remarkable potential as therapeutics for medical or veterinary uses, alone or in combination with classical antimicrobials. Their interest is even higher now that the resistance to the antibacterials used in therapeutics is growing. In this review we explore exciting opportunities for bacteriocin and probiotic applications, highlighting the possibilities for new and innovative research in order to give the necessary attention to this type of natural molecules that exhibit a great potential.

Keywords: Animal health, antibiotics, antimicrobial, antiviral, antifungal- peptides, bacteriocins, drug resistance, lactic acid bacteria, multiresistant bacteria, oral cavity, probiotic, skin, tuberculosis, vagina, bacteriocin-producer probiotic organisms, food fermentations, nisin


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy